Real-world localization of cancer in lungs with a commercially available folate receptor-targeted fluorescent agent for intraoperative molecular imaging
This report of early postmarketing experience with pafolacianine for cancer in the lung demonstrated a high rate of nodule localization. These early experiences further reinforce IMI as an adjunct to surgical resection that may enhance the ability to perform minimally invasive parenchymal-sparing operations.
Authors
- Evan T. Alicuben (ORCID: https://orcid.org/0000-0002-5767-9435)
- Ryan M. Levy
- Navid Ajabshir
- Nicholas Baker (ORCID: https://orcid.org/0000-0002-0061-8930)
- Inderpal S. Sarkaria
Institutions
- Southwestern Medical Center (US)
- University of Pittsburgh Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JTCVS Techniques
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1016/j.xjtc.2024.12.011
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00